High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression von KUIPER, R. P, SCHOENMAKERS, E. F. P. M, VAN REIJMERSDAL, S. V, HEHIR-KWA, J. Y, VAN KESSEL, A. Geurts, VAN LEEUWEN, F. N, HOOGERBRUGGE, P. M

Volltext

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL von Kuiper, R P, Waanders, E, van der Velden, V H J, van Reijmersdal, S V, Venkatachalam, R, Scheijen, B, Sonneveld, E, van Dongen, J J M, Veerman, A J P, van Leeuwen, F N, Geurts van Kessel, A, Hoogerbrugge, P M

Volltext

Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study von Boer, J M, van der Veer, A, Rizopoulos, D, Fiocco, M, Sonneveld, E, de Groot-Kruseman, H A, Kuiper, R P, Hoogerbrugge, P, Horstmann, M, Zaliova, M, Palmi, C, Trka, J, Fronkova, E, Emerenciano, M, do Socorro Pombo-de-Oliveira, M, Mlynarski, W, Szczepanski, T, Nebral, K, Attarbaschi, A, Venn, N, Sutton, R, Schwab, C J, Enshaei, A, Vora, A, Stanulla, M, Schrappe, M, Cazzaniga, G, Conter, V, Zimmermann, M, Moorman, A V, Pieters, R, den Boer, M L

Volltext

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia von Waanders, E, van der Velden, V H J, van der Schoot, C E, van Leeuwen, F N, van Reijmersdal, S V, de Haas, V, Veerman, A J, van Kessel, A Geurts, Hoogerbrugge, P M, Kuiper, R P, van Dongen, J J M

Volltext

Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome von Jongmans, M C J, Kuiper, R P, Carmichael, C L, Wilkins, E J, Dors, N, Carmagnac, A, Schouten-van Meeteren, A Y N, Li, X, Stankovic, M, Kamping, E, Bengtsson, H, Schoenmakers, E F P M, van Kessel, A Geurts, Hoogerbrugge, P M, Hahn, C N, Brons, P P, Scott, H S, Hoogerbrugge, N

Volltext

Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia von Marke, R, Havinga, J, Cloos, J, Demkes, M, Poelmans, G, Yuniati, L, van Ingen Schenau, D, Sonneveld, E, Waanders, E, Pieters, R, Kuiper, R P, Hoogerbrugge, P M, Kaspers, G J L, van Leeuwen, F N, Scheijen, B

Volltext

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences von Waanders, E, Scheijen, B, Jongmans, M C J, Venselaar, H, van Reijmersdal, S V, van Dijk, A H A, Pastorczak, A, Weren, R D A, van der Schoot, C E, van de Vorst, M, Sonneveld, E, Hoogerbrugge, N, van der Velden, V H J, Gruhn, B, Hoogerbrugge, P M, van Dongen, J J M, Geurts van Kessel, A, van Leeuwen, F N, Kuiper, R P

Volltext

Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development von Tijchon, Esther, van Emst, Liesbeth, Yuniati, Laurensia, van Ingen Schenau, Dorette, Havinga, Jørn, Rouault, Jean-Pierre, Hoogerbrugge, Peter M, van Leeuwen, Frank N, Scheijen, Blanca

Volltext

Patient reported outcomes in pediatric oncology practice: Suggestions for future usage by parents and pediatric oncologists von Schepers, S.A., Engelen, V.E., Haverman, L., Caron, H.N., Hoogerbrugge, P.M., Kaspers, G.J.L., Egeler, R.M., Grootenhuis, M.A.

Volltext

High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation von Marshall, G M, Dalla Pozza, L, Sutton, R, Ng, A, de Groot-Kruseman, H A, van der Velden, V H, Venn, N C, van den Berg, H, de Bont, E S J M, Maarten Egeler, R, Hoogerbrugge, P M, Kaspers, G J L, Bierings, M B, van der Schoot, E, van Dongen, J, Law, T, Cross, S, Mueller, H, de Haas, V, Haber, M, Révész, T, Alvaro, F, Suppiah, R, Norris, M D, Pieters, R

Volltext

Symptoms in the palliative phase of children with cancer von Theunissen, J.M.J., Hoogerbrugge, P.M., van Achterberg, T., Prins, J.B., Vernooij-Dassen, M.J.F.J., van den Ende, C.H.M.

Volltext

TET2 mutations in childhood leukemia von Langemeijer, S M C, Jansen, J H, Hooijer, J, van Hoogen, P, Stevens-Linders, E, Massop, M, Waanders, E, van Reijmersdal, S V, Stevens-Kroef, M J P L, Zwaan, C M, van den Heuvel-Eibrink, M M, Sonneveld, E, Hoogerbrugge, P M, Geurts van Kessel, A, Kuiper, R P

Volltext

Independent development of lymphoid and histiocytic malignancies from a shared early precursor von Waanders, E, Hebeda, K M, Kamping, E J, Groenen, P J T A, Simons, A, Hoischen, A, Jongmans, M C J, Hoogerbrugge, P M, van Leeuwen, F N, Kuiper, R P, te Loo, D M W M

Volltext

Simulating Microscopic Hydrodynamic Phenomena with Dissipative Particle Dynamics von Hoogerbrugge, P. J, Koelman, J. M. V. A

Volltext

Dynamic Simulations of Hard-Sphere Suspensions Under Steady Shear von Koelman, J. M. V. A, Hoogerbrugge, P. J

Volltext

The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer von Hagleitner, M M, Coenen, M J H, Aplenc, R, Patiño-Garcia, A, Chiusolo, P, Gemmati, D, De Mattei, M, Ongaro, A, Krajinovic, M, Hoogerbrugge, P M, Vermeulen, S H H M, te Loo, D M W M

Volltext

3405 The role of pharmacogenetics in osteosarcoma von Hagleitner, M, Coenen, M, Gelderblom, H, Vos, H, De Bont, E, Van der Graaf, W, Hoogerbrugge, P, Guchelaar, H.J, Loo, M. Te

Volltext

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more von HEEMSKERK, M. B. A, VAN WALRAVEN, S. M, DONKER, A. E, HOOGERBRUGGE, P. M, VAN ROOD, J. J, CLAAS, F. H. J, OUDSHOORN, M, CORNELISSEN, J. J, BARGE, R. M. Y, BREDIUS, R. G. M, EGELER, R. M, LIE, Jlwtj, REVESZ, T, SINTNICOLAAS, K, WULFFRAAT, N. M

Volltext

Allogeneic bone marrow transplantation for lysosomal storage diseases von Hoogerbrugge, P.M., Brouwer, O.F., Bordigoni, P., Cornu, G., Kapaun, P., Ortega, J.J., O'Meara, A., Souillet, G., Frappaz, D., Blanche, S., Fischer, A., Ringden, O.

Volltext

Outcome after first relapse in children with acute lymphoblastic leukemia: A report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol von van den Berg, H., de Groot-Kruseman, H.A., Damen-Korbijn, C.M., de Bont, E.S.J.M, Schouten-van Meeteren, A.Y.N., Hoogerbrugge, P.M.

Volltext